Literature DB >> 33485367

Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.

Fangyu Chen1,2, Bing Xu1,2, Jie Li1, Xi Yang3,4, Junjie Gu1,2, Xijuan Yao1,2, Xinchen Sun5.   

Abstract

BACKGROUND: Radiotherapy resistance is a major obstacle in the treatment of oesophageal squamous cell carcinoma (OSCC). Hypoxia is a critical cause of radioresistance. However, the communication between hypoxic cells and aerobic cells via exosomes during the transfer of radiation resistance remains unclear.
METHODS: Exo-miR-340-5p levels were analysed by RNA-seq and qRT-PCR. We co-cultured OSCC cells with isolated normoxic and hypoxic exosomes to study their impact on radiosensitivity. We used a specific exo-miR-340-5p mimic and knock-down retrovirus to explore the role of this miRNA in the transfer of radioresistance from hypoxic to normoxic cells. Dual-luciferase reporter and RIP assays were used to verify KLF10 as a putative target of miR-340-5p. Several in vitro assays were conducted and xenograft models were established to investigate the effect of exo-miR-340-5p on OSCC radiosensitivity. The plasma exo-miR-340-5p levels in OSCC patients were analysed to study the clinical value of this parameter.
RESULTS: Hypoxic exosomes alleviated radiation-induced apoptosis and accelerated DNA damage repair. miR-340-5p was highly expressed in hypoxic exosomes and was transferred into normoxic cells, where it induced radioresistance. Overexpression of miR-340-5p in normoxic OSCC cells mimicked the radioresistance of cells co-cultured with hypoxic exosomes. Knockdown of miR-340-5p in hypoxic exosomes reversed the radioresistance effect, indicating that exo-miR-340-5p is critical for hypoxic EV-transferred radioresistance. KLF10 was identified as the direct target of miR-340-5p. Moreover, metformin was found to increase the expression of KLF10 and enhance the radiosensitivity of OSCC. Higher levels of miR-340-5p in the plasma exosomes from OSCC patients are related to a poorer radiotherapy response and prognosis.
CONCLUSIONS: Hypoxic tumour cell-derived exosomal miR-340-5p confers radioresistance in OSCC by targeting KLF10/UVRAG, suggesting that miR-340-5p could be a potential biomarker and therapeutic target for the enhancement of radiosensitivity in OSCC. Metformin can increase KLF10 expression, which ameliorates the radioresistance induced by exo-miR-340-5p transfer. Therefore, metformin could be further investigated as a therapeutic option for the treatment of OSCC.

Entities:  

Keywords:  Extracellular vesicles; Hypoxia; Oesophageal cancer; Radiotherapy; miRNA

Year:  2021        PMID: 33485367      PMCID: PMC7825246          DOI: 10.1186/s13046-021-01834-9

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  35 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

Review 2.  Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.

Authors:  Mian Xi; Steven H Lin
Journal:  Expert Rev Anticancer Ther       Date:  2017-05-22       Impact factor: 4.512

Review 3.  Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.

Authors:  Ahmed Salem; Marie-Claude Asselin; Bart Reymen; Alan Jackson; Philippe Lambin; Catharine M L West; James P B O'Connor; Corinne Faivre-Finn
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

4.  Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.

Authors:  P Zhao; W Ma; Z Hu; Y Zhang; S Zhang; Y Wang
Journal:  J Endocrinol Invest       Date:  2018-02-13       Impact factor: 4.256

Review 5.  Integrating liquid biopsies into the management of cancer.

Authors:  Giulia Siravegna; Silvia Marsoni; Salvatore Siena; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2017-03-02       Impact factor: 66.675

Review 6.  Oesophageal cancer.

Authors:  Jesper Lagergren; Elizabeth Smyth; David Cunningham; Pernilla Lagergren
Journal:  Lancet       Date:  2017-06-22       Impact factor: 79.321

7.  Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells.

Authors:  Fangyu Chen; Li Chu; Jie Li; Yu Shi; Bing Xu; Junjie Gu; Xijuan Yao; Meng Tian; Xi Yang; Xinchen Sun
Journal:  Thorac Cancer       Date:  2020-01-10       Impact factor: 3.500

8.  Oesophageal cancer survival in Europe: a EUROCARE-4 study.

Authors:  A T Gavin; S Francisci; R Foschi; D W Donnelly; V Lemmens; H Brenner; L A Anderson
Journal:  Cancer Epidemiol       Date:  2012-08-19       Impact factor: 2.984

9.  Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Xiaoli Zhang; Minghuan Li; Xue Meng; Li Kong; Yan Zhang; Guangsheng Wei; Xiqin Zhang; Fang Shi; Man Hu; Guoli Zhang; Jinming Yu
Journal:  Radiat Oncol       Date:  2014-02-26       Impact factor: 3.481

10.  Cancer survival in China, 2003-2005: a population-based study.

Authors:  Hongmei Zeng; Rongshou Zheng; Yuming Guo; Siwei Zhang; Xiaonong Zou; Ning Wang; Limei Zhang; Jingao Tang; Jianguo Chen; Kuangrong Wei; Suqin Huang; Jian Wang; Liang Yu; Deli Zhao; Guohui Song; Jianshun Chen; Yongzhou Shen; Xiaoping Yang; Xiaoping Gu; Feng Jin; Qilong Li; Yanhua Li; Hengming Ge; Fengdong Zhu; Jianmei Dong; Guoping Guo; Ming Wu; Lingbin Du; Xibin Sun; Yutong He; Michel P Coleman; Peter Baade; Wanqing Chen; Xue Qin Yu
Journal:  Int J Cancer       Date:  2014-10-03       Impact factor: 7.396

View more
  16 in total

1.  miR-340-5p mediates the therapeutic effect of mesenchymal stem cells on corneal neovascularization.

Authors:  Jian Pan; Xu Luo; Shujue Zhao; Jianmin Li; Zipei Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-08       Impact factor: 3.535

Review 2.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

3.  Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP.

Authors:  Feng Yu; Ying Lin; Guojie Tan; Maomao Ai; Huicheng Gong; Wei Liu; Jiali Huang; Zirou Zou
Journal:  Cell Cycle       Date:  2022-02-13       Impact factor: 5.173

Review 4.  Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer.

Authors:  Mu Liu; Xiaofang Zhou; Jie Tang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-19

5.  Follicular fluid-derived exosomal miR-143-3p/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome.

Authors:  Jianping Cao; Peng Huo; Kuiqing Cui; Huimei Wei; Junna Cao; Jinyuan Wang; Qingyou Liu; Xiaocan Lei; Shun Zhang
Journal:  Cell Commun Signal       Date:  2022-05-09       Impact factor: 7.525

6.  Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway.

Authors:  Jiewei Lin; Shuyu Zhai; Siyi Zou; Zhiwei Xu; Jun Zhang; Lingxi Jiang; Xiaxing Deng; Hao Chen; Chenghong Peng; Jiaqiang Zhang; Baiyong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-11

7.  A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer.

Authors:  Jiahang Song; Shuming Zhang; Yuanyuan Sun; Junjie Gu; Ziqi Ye; Xinchen Sun; Qiyun Tang
Journal:  J Oncol       Date:  2021-09-21       Impact factor: 4.375

Review 8.  Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.

Authors:  Jian Wang; Bing-Lin Yue; Yong-Zhen Huang; Xian-Yong Lan; Wu-Jun Liu; Hong Chen
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

Review 9.  Tumor-derived exosomes in hypoxic microenvironment: release mechanism, biological function and clinical application.

Authors:  Da Qian; Yaoyao Xie; Mingyao Huang; Jianfeng Gu
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

Review 10.  The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma.

Authors:  Jie Li; Juan Sun; Zhen Liu; Ziyang Zeng; Siwen Ouyang; Zimu Zhang; Mingwei Ma; Weiming Kang
Journal:  Front Cell Dev Biol       Date:  2022-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.